Jeffrey P. Mornhinweg

Array ( [id] => 11074281 [patent_doc_number] => 20160271244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'METHOD OF INDUCING THE PRODUCTION OF PROTECTIVE ANTI-HIV-1 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 15/056655 [patent_app_country] => US [patent_app_date] => 2016-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 114 [patent_figures_cnt] => 114 [patent_no_of_words] => 17281 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15056655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11053357 [patent_doc_number] => 20160250318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'BIVALENT SWINE INFLUENZA VIRUS VACCINE' [patent_app_type] => utility [patent_app_number] => 15/050640 [patent_app_country] => US [patent_app_date] => 2016-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33057 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10820517 [patent_doc_number] => 20160166682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'Treatment of Infection' [patent_app_type] => utility [patent_app_number] => 15/049824 [patent_app_country] => US [patent_app_date] => 2016-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7462 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15049824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14637141 [patent_doc_number] => 10363299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-30 [patent_title] => Compositions and methods for preventing and treating rhinovirus infections [patent_app_type] => utility [patent_app_number] => 15/551315 [patent_app_country] => US [patent_app_date] => 2016-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 30408 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13209621 [patent_doc_number] => 10119172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Methods and reagents for detecting ebola virus [patent_app_type] => utility [patent_app_number] => 15/552157 [patent_app_country] => US [patent_app_date] => 2016-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19441 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12157392 [patent_doc_number] => 20180028658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'ANTIBODY-DRUG CONJUGATES FOR REDUCING THE LATENT HIV RESERVOIR' [patent_app_type] => utility [patent_app_number] => 15/551130 [patent_app_country] => US [patent_app_date] => 2016-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13427 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10806534 [patent_doc_number] => 20160152692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'INFLUENZA VIRUS-NEUTRALIZING ANTIBODY AND SCREENING METHOD THEREFOR' [patent_app_type] => utility [patent_app_number] => 15/017246 [patent_app_country] => US [patent_app_date] => 2016-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 20808 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15017246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13763585 [patent_doc_number] => 10174127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => Human neutralizing antibodies binding to influenza neuraminidase [patent_app_type] => utility [patent_app_number] => 15/548919 [patent_app_country] => US [patent_app_date] => 2016-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9659 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13942499 [patent_doc_number] => 10206994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-19 [patent_title] => RNA virus attenuation by alteration of mutational robustness and sequence space [patent_app_type] => utility [patent_app_number] => 15/545481 [patent_app_country] => US [patent_app_date] => 2016-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 44 [patent_no_of_words] => 41045 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10767873 [patent_doc_number] => 20160114030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'Nucleic Acid Molecule Encoding Hepatitis B Virus Core Protein And Surface Antigen Protein And Vaccine Comprising The Same' [patent_app_type] => utility [patent_app_number] => 14/978329 [patent_app_country] => US [patent_app_date] => 2015-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 25914 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14978329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10988881 [patent_doc_number] => 20160185825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'ENGINEERED OUTER DOMAIN (EOD) OF HIV GP120 AND MUTANTS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/978132 [patent_app_country] => US [patent_app_date] => 2015-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26632 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14978132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13209189 [patent_doc_number] => 10118951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Multimerization of recombinant protein by fusion to a sequence from lamprey [patent_app_type] => utility [patent_app_number] => 15/536726 [patent_app_country] => US [patent_app_date] => 2015-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 14321 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13093327 [patent_doc_number] => 10065994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-04 [patent_title] => Norovirus derived immunogenic compositions and methods [patent_app_type] => utility [patent_app_number] => 14/946324 [patent_app_country] => US [patent_app_date] => 2015-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 39387 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 236 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14946324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13661287 [patent_doc_number] => 10160795 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-25 [patent_title] => Neutralizing antibodies to Ebola virus glycoprotein and their use [patent_app_type] => utility [patent_app_number] => 15/526661 [patent_app_country] => US [patent_app_date] => 2015-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 51 [patent_no_of_words] => 38304 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15526661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12059000 [patent_doc_number] => 20170335345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF HEPATITIS C' [patent_app_type] => utility [patent_app_number] => 15/524879 [patent_app_country] => US [patent_app_date] => 2015-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9188 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10784409 [patent_doc_number] => 20160130565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'Method to Produce Virus in Cultured Cells' [patent_app_type] => utility [patent_app_number] => 14/935061 [patent_app_country] => US [patent_app_date] => 2015-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7275 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14935061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14085699 [patent_doc_number] => 10238729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-26 [patent_title] => Cancer and skin lesion treatment [patent_app_type] => utility [patent_app_number] => 14/921648 [patent_app_country] => US [patent_app_date] => 2015-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4737 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14921648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10738684 [patent_doc_number] => 20160084835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'METHODS FOR DIAGNOSING INFECTIOUS DISEASES USING ADSORPTION MEDIA' [patent_app_type] => utility [patent_app_number] => 14/885729 [patent_app_country] => US [patent_app_date] => 2015-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11641 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14885729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10684402 [patent_doc_number] => 20160030548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'Influenza Nucleic Acid Molecules And Vaccines Made Therefrom' [patent_app_type] => utility [patent_app_number] => 14/880715 [patent_app_country] => US [patent_app_date] => 2015-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16910 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14880715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18519275 [patent_doc_number] => 11709163 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Methods for simultaneous determination of serological profile and estimation of duration post HIV infection [patent_app_type] => utility [patent_app_number] => 15/509841 [patent_app_country] => US [patent_app_date] => 2015-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8115 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15509841 [rel_patent_id] =>[rel_patent_doc_number] =>)